Growth Factor-free Proliferation and Differentiation of Stem Cell
Overview
Stem cell therapy holds great promise for treating a wide range of medical conditions. However, conventional methods for cultivating stem cells are often costly and result in the production of cancerous cells. Growth Factor-free Proliferation & Differentiation of Stem Cell technology offers a solution to these problems by providing a method for growing stem cells without the use of animals or biochemical growth factors.
Project-in-charge
Prof. Ken YUNG
Professor, Department of Biology
Key Features
The technology uses inorganic sculptured extracellular nanomatrices (iSECnMs) to stimulate growth and differentiation of stem cells.
- iSECnMs is biocompatible and low-cost, making it well-suited for mass production.
- The device stimulates growth and differentiation of stem cells by nanoscopic structures on its surfaces while inhibiting other directors of differentiation, thus reducing the risk of inflammation or cancer cell formation.
Technology Readiness Level
Potential Applications
- Regenerative therapy for a variety of medical conditions.
- Treatment for neurodegenerative diseases, chronic diseases, and joint diseases.
Market Outlook & Unique Value Proposition
The global stem cell therapy market is projected to reach a total revenue value of $558 million by 2027. It is expected to have a compound annual growth rate (CAGR) of 16.8% from 2022 to 2027, with a revenue size of approximately $257 million in 2022. The market for stem cell therapy is growing rapidly, with an increasing demand for effective and low-cost treatments. iSECnMs offers a unique solution to the problems associated with conventional stem cell cultivation methods, positioning it well for growth and success in the market.
The use of iSECnMs for stimulating growth and differentiation of stem cells provides a safer and more reliable method for producing healthy and functional cells for use in regenerative therapy. The low-cost nature of the technology also makes it accessible to a wider range of patients and healthcare providers. Overall, iSECnMs has the potential to revolutionize the field of regenerative medicine and improve the lives of millions of patients suffering from a variety of medical conditions.
Representative Publications
YUNG, Kin Lam (Inventor) ; HUANG, Jeffery (Inventor) ; LUI, Cathy N P (Inventor). / Growth Factor-Free Proliferation and Differentiation of Neural Stem Cells on Inorganic Extracellular Nanomatrices (Granted). Patent No.: EP3464568B1. Apr 10, 2019.
Patents
- US Patent No. US 10,619,135
- China Patent No. ZL 201780031011.8
- European Patent No. EP3464568B1